Waki Kayoko 和氣加容子

Researcher Number	40649597
Affiliation (Current)	2025: 公益財団法人放射線影響研究所, バイオサンプル研究センター, 研究員
Affiliation (based on the past Project Information) *help	2025: 公益財団法人放射線影響研究所, バイオサンプル研究センター, 研究員 2021 – 2022: 久留米大学, 付置研究所, 講師 2018 – 2020: 久留米大学, 付置研究所, 助教 2017: 久留米大学, 付置研究所, 研究員
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor therapeutics Except Principal Investigator Basic Section 63020:Radiation influence-related / Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords	Principal Investigator がん免疫療法 / 抗腫瘍免疫 / 腫瘍由来ミトコンドリアDAMPｓ / DAMPｓ / がん免疫 / DAMPs / formyl peptide / ミトコンドリア / ホルミルペプチド / ミトコンドリアDAMPs … More / ペプチドワクチン / 腫瘍免疫 / 癌 / 経皮ワクチン / がんペプチドワクチン … More Except Principal Investigator クロマチン構造 / 体細胞変異 / DNA損傷修復 / 放射線被曝 / 造血幹細胞 / ＤＡＭＰｓ / 抗腫瘍免疫 / マウス / 腫瘍微小環境 / ダメージ関連分子パターン / 免疫療法 / 腫瘍免疫 / ゲノム編集 / HMGB1 Less

Genome-wide mapping of radiation-induced DNA double-strand breaks to elucidate mutation processes
- Principal Investigator
  
  田邉修
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 63020:Radiation influence-related
- Research Institution
  Radiation Effects Research Foundation
Roles of tumor-derived mitochondrial DAMPs in anti-rumor immunity and application to cancer immunotherapyPrincipal Investigator
- Principal Investigator
  
  Waki Kayoko
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Kurume University
Role of HMGB1 on anti-tumor immunity and its application for cancer immunotherapy
- Principal Investigator
  
  Yamada Akira
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Kurume University
A basic research to develop cancer peptide vaccine for transdermal immunizationPrincipal Investigator
- Principal Investigator
  
  Waki Kayoko
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Kurume University

All 2022 2021 2020 2019 2018 2017

All Journal Article Presentation

[Journal Article] Knockout of high-mobility group box 1 in B16F10 melanoma cells induced host immunity-mediated suppression of in vivo tumor growth.2022
- Author(s)
  Yokomizo K, Waki K, Ozawa M, Yamamoto K, Ogasawara S, Yano H, Yamada A.
- Journal Title
  
  Med Oncol.
  
  Volume: 39 Issue: 5 Pages: 58-58
- DOI
  10.1007/s12032-022-01659-2
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07742
[Journal Article] Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer.2017
- Author(s)
  Waki K, Kawano K, Tsuda N, Ushijima K, Itoh K, Yamada A.
- Journal Title
  
  Journal of Immunology Research
  
  Volume: 2017 Pages: 1423683-1423683
- DOI
  10.1155/2017/1423683
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26430176, KAKENHI-PROJECT-17K07229
[Journal Article] Immunological efficacy of herbal medicines in prostate cancer patients treated by personalized peptide vaccine2017
- Author(s)
  Koga Noriko、Moriya Fukuko、Waki Kayoko、Yamada Akira、Itoh Kyogo、Noguchi Masanori
- Journal Title
  
  Cancer Science
  
  Volume: 108 Issue: 12 Pages: 2326-2332
- DOI
  10.1111/cas.13397
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K07229
[Presentation] Effects of inhibition of mitochondrial N-formyl peptides as damage-associated molecular patterns on anti-tumor immunity2022
- Author(s)
  和氣加容子
- Organizer
  第82回日本癌学会学術総会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K07668
[Presentation] 腫瘍由来ダメージ関連分子パターンHMGB1の抗腫瘍免疫における役割2021
- Author(s)
  横溝香奈子、和氣加容子、山田亮
- Organizer
  日本癌学会総会
- Data Source
  KAKENHI-PROJECT-19K07742
[Presentation] Role of mitochondrial N-formyl peptides as damage-associated molecular patterns on anti-tumor immunity2021
- Author(s)
  和氣加容子
- Organizer
  日本癌学会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K07668
[Presentation] 腫瘍由来ダメージ関連分子パターンHMGB1の抗腫瘍免疫における役割2021
- Author(s)
  横溝香奈子、和氣加容子、山田亮
- Organizer
  日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-19K07742
[Presentation] Role of tumor-derived high-mobility group box 1 (HMGB1) on anti-tumor immunity2020
- Author(s)
  横溝香奈子、和氣加容子、山田　亮
- Organizer
  日本癌学会
- Data Source
  KAKENHI-PROJECT-19K07742
[Presentation] Plasma cell-free DNA integrity and the prognosis in the advanced endometrial cancer patients with peptide vaccination2019
- Author(s)
  和氣加容子
- Organizer
  第７８回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K07229
[Presentation] 末梢血セルフリーDNA integrityはペプチドワクチン療法において有用なバイオマーカーとなりうる：非小細胞肺がんでの解析2018
- Author(s)
  和氣加容子、山田亮
- Organizer
  第22回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-17K07229
[Presentation] Plasma cell-free DNA integrity analyses for ovarian and non-small cell lung cancer patients with peptide vaccination2018
- Author(s)
  和氣加容子、山田亮
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K07229
[Presentation] 古典的Ｔ細胞サブセットCD4、CD8(末梢血中)の変動はペプチドワクチン療法の優れた予後予測因子となりうる：進行・再発卵巣がんでの解析2017
- Author(s)
  和氣加容子
- Organizer
  第21回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-17K07229
[Presentation] Integrity of cell-free DNA in plasma as a useful biomarker for responses to peptide vaccine in ovarian cancer patients2017
- Author(s)
  和氣加容子
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K07229

1. Yamada Akira (50158177)

# of Collaborated Projects: 3 results

# of Collaborated Products: 8 results
2. 田邉修 (70221398)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 松田由喜子 (10735301)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Waki Kayoko 和氣 加容子

Research Projects

Research Products

Co-Researchers

Genome-wide mapping of radiation-induced DNA double-strand breaks to elucidate mutation processes

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Roles of tumor-derived mitochondrial DAMPs in anti-rumor immunity and application to cancer immunotherapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Role of HMGB1 on anti-tumor immunity and its application for cancer immunotherapy

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

A basic research to develop cancer peptide vaccine for transdermal immunizationPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Knockout of high-mobility group box 1 in B16F10 melanoma cells induced host immunity-mediated suppression of in vivo tumor growth.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Immunological efficacy of herbal medicines in prostate cancer patients treated by personalized peptide vaccine2017

Author(s)

Journal Title

DOI

Data Source

[Presentation] Effects of inhibition of mitochondrial N-formyl peptides as damage-associated molecular patterns on anti-tumor immunity2022

Author(s)

Organizer

Data Source

[Presentation] 腫瘍由来ダメージ関連分子パターンHMGB1の抗腫瘍免疫における役割2021

Author(s)

Organizer

Data Source

[Presentation] Role of mitochondrial N-formyl peptides as damage-associated molecular patterns on anti-tumor immunity2021

Author(s)

Organizer

Data Source

[Presentation] 腫瘍由来ダメージ関連分子パターンHMGB1の抗腫瘍免疫における役割2021

Author(s)

Organizer

Data Source

[Presentation] Role of tumor-derived high-mobility group box 1 (HMGB1) on anti-tumor immunity2020

Author(s)

Organizer

Data Source

[Presentation] Plasma cell-free DNA integrity and the prognosis in the advanced endometrial cancer patients with peptide vaccination2019

Author(s)

Organizer

Data Source

[Presentation] 末梢血セルフリーDNA integrityはペプチドワクチン療法において有用なバイオマーカーとなりうる：非小細胞肺がんでの解析2018

Author(s)

Organizer

Data Source

[Presentation] Plasma cell-free DNA integrity analyses for ovarian and non-small cell lung cancer patients with peptide vaccination2018

Author(s)

Organizer

Data Source

[Presentation] 古典的Ｔ細胞サブセットCD4、CD8(末梢血中)の変動はペプチドワクチン療法の優れた予後予測因子となりうる：進行・再発卵巣がんでの解析2017

Author(s)

Organizer

Data Source

[Presentation] Integrity of cell-free DNA in plasma as a useful biomarker for responses to peptide vaccine in ovarian cancer patients2017

Waki Kayoko 和氣加容子